Managing the patient presenting with xerostomia: a review

Nederfors, 1997, Prevalence of perceived symptoms of dry mouth in an adult Swedish population: relation to age, sex and pharmacotherapy, Community dental oral Epidemiol, 25, 211, 10.1111/j.1600-0528.1997.tb00928.x

Moore, 2001, Type 1 diabetes mellitus, xerostomia and salivary flow rates, Oral surg Oral med Oral pathol Oral radiol Endod, 92, 281, 10.1067/moe.2001.117815

Fox, 1987, Subjective reports of xerostomia and objective measures of salivary gland performance, J Am Dent Assoc, 115, 581, 10.1016/S0002-8177(87)54012-0

Sreebny, 1989, Xerostomia part II: relationship of nonoral symptoms, drugs and diseases, Oral surg Oral med Oral pathol, 68, 419, 10.1016/0030-4220(89)90140-0

Dirix, 2008, The influence of xerostomia after radiotherapy on quality of life, Support Care Cancer, 16, 171, 10.1007/s00520-007-0300-5

Davies, 2001, Xerostomia in patients with advanced cancer, J Pain Symptom Manage, 22, 820, 10.1016/S0885-3924(01)00318-9

Porter, 2000, Adverse drug reactions in the mouth, Clin dermatol, 18, 525, 10.1016/S0738-081X(00)00143-7

Astor, 1999, Xerostomia: a prevalent condition in the elderly, Ear Nose Throat J, 78, 476, 10.1177/014556139907800707

Mersel, 1989, Oral health status and dental needs in a geriatric institutionalised population in Paris, Gerodontology, 8, 47, 10.1111/j.1741-2358.1989.tb00403.x

Navazesh, 1992, Clinical criteria for the diagnosis of salivary gland hypofunction, J Dent Res, 71, 1363, 10.1177/00220345920710070301

Bjornstrom, 1990, Comparison between saliva stimulants and saliva substitutes in patients with symptoms related to dry mouth, Swed Dent J, 14, 153

Levine, 1987, Artificial salivas: present and future, J Dent Res, 66, 693, 10.1177/00220345870660S215

Risheim, 1993, Salivary stimulation by chewing gum and lozenges in rheumatic patients with xerostomia, Scand J Dent Res, 101, 40

Anneroth, 1980, Effect of saliva stimulants on cervical root surfaces in vitro, Scand J Dent Res, 80, 214

Rieke, 1995, oral Pilocarpine for radiation induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials, Int J Radiat Oncol Biol Phys, 31, 661, 10.1016/0360-3016(94)00361-N

Le Veque, 1993, A multicentre randomized double blind, placebo controlled dose titration study of oral pilocarpine for treatment of radiation induced xerostomia in head and neck cancer patients, J Clin Oncol, 11, 1124, 10.1200/JCO.1993.11.6.1124

Fox, 1986, Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction, Oral surg Oral med Oral pathol, 61, 243, 10.1016/0030-4220(86)90369-5

Epstein, 1994, A clinical trial of bethanecol in patients with xerostomia after radiation therapy. A pilot study, Oral surg Oral med Oral pathol, 77, 610, 10.1016/0030-4220(94)90320-4

Joensuu, 1993, Pilocarpine and carbacholine in treatment of radiation induced xerostomia, Radiother Oncol, 26, 33, 10.1016/0167-8140(93)90023-2

Teichman, 1987, Disopyramide-pyridostigmine interaction: selective reversal of anticholinergic symptoms with preservation of antiarrhythmic effect, J Am coll cardiol, 10, 633, 10.1016/S0735-1097(87)80207-3

Petrone, 2002, A double blind, randomized, placebo-controlled study of Cevimeline in SjÖgrens syndrome patients with xerostomia and keratoconjunctivitis sicca, Arthritis Rheum, 46, 748, 10.1002/art.510

Koukourakis, 2002, Amifostine in clinical oncology. Current use and future implications, Anticancer Drugs, 13, 181, 10.1097/00001813-200203000-00001

Blom, 1996, Acupuncture treatment of patients with radiation-induced xerostomia, Eur J Cancer B Oral Oncol, 32B, 182, 10.1016/0964-1955(95)00085-2